Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon

被引:84
作者
Ahmad, Rizwan [1 ]
Rasheed, Zafar [1 ]
Ahsan, Haseeb [2 ]
机构
[1] Sardar Bhagwan Singh Postgrad Inst Biomed Sci & R, Dept Biochem, Dehra Dun 248161, Uttar Pradesh, India
[2] Hamdard Univ, Fac Sci, Dept Med Elementol & Toxicol, New Delhi 110062, India
关键词
Autoimmunity; Cytotoxicity; Immunotoxicology; Nitric Oxide; Peroxynitrite; POLY(ADP-RIBOSE) POLYMERASE ACTIVATION; ISCHEMIA-REPERFUSION INJURY; DIABETIC ENDOTHELIAL DYSFUNCTION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; OXIDIZED LIPID DERIVATIVES; NITRIC-OXIDE REGULATION; TYROSINE NITRATION; DNA-DAMAGE; OXIDATIVE DAMAGE; HEART-FAILURE;
D O I
10.1080/08923970802709197
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reactive nitrogen species include nitric oxide (center dot NO), peroxynitrite (ONOO-) and nitrogen dioxide radical (NO2 center dot). Peroxynitrite is a reactive oxidant, produced from nitric oxide (center dot NO) and superoxide anion (O-2(center dot-)), that reacts with a variety of biological macromolecules. It is produced in the body in response to physiological stress and environmental toxins. It is a potent trigger of oxidative protein and DNA damage-including DNA strand breakage and base modification. It activates the nuclear enzyme poly-ADP ribose polymerase (PARP) resulting in energy depletion and apoptosis/necrosis of cells. Peroxynitrite generation is a crucial pathological mechanism in stroke, diabetes, inflammation, neurodegeneration, cancer, etc. Peroxynitrite modified DNA may also lead to the generation of autoantibodies in various autoimmune disorders such as systemic lupus erythematosus (SLE). In chronic inflammatory diseases, peroxynitrite formed by phagocytic cells may cause damage to DNA, generating neoepitopes leading to the production of autoantibodies. Hence, understanding the pathophysiology of peroxynitrite could lead to important therapeutic interventions.
引用
收藏
页码:388 / 396
页数:9
相关论文
共 103 条
[91]   Poly(ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation [J].
Szabó, G ;
Bährle, S ;
Stumpf, N ;
Sonnenberg, K ;
Szabó, T ;
Pacher, P ;
Csont, T ;
Schulz, R ;
Dengler, TJ ;
Liaudet, L ;
Jagtap, PG ;
Southan, GJ ;
Vahl, CF ;
Hagl, S ;
Szabó, C .
CIRCULATION RESEARCH, 2002, 90 (01) :100-106
[92]   Development of novel, water-soluble inhibitors of poly(adenosine 5′-diphosphate ribose) synthetase activity for use in shock and ischemia-reperfusion injury [J].
Thiemermann, C .
CRITICAL CARE MEDICINE, 2002, 30 (05) :1163-1165
[93]   Peroxynitrite-induced DNA damage in the supF gene:: correlation with the mutational spectrum [J].
Tretyakova, NY ;
Burney, S ;
Pamir, B ;
Wishnok, JS ;
Dedon, PC ;
Wogan, GN ;
Tannenbaum, SR .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 447 (02) :287-303
[94]  
Ungvari Zoltan, 2005, Current Vascular Pharmacology, V3, P221, DOI 10.2174/1570161054368607
[95]   Synthesis of peroxynitrite in a two-phase system using isoamyl nitrite and hydrogen peroxide [J].
Uppu, RM ;
Pryor, WA .
ANALYTICAL BIOCHEMISTRY, 1996, 236 (02) :242-249
[96]   INTERACTIONS OF PEROXYNITRITE WITH HUMAN PLASMA AND ITS CONSTITUENTS - OXIDATIVE DAMAGE AND ANTIOXIDANT DEPLETION [J].
VANDERVLIET, A ;
SMITH, D ;
ONEILL, CA ;
KAUR, H ;
DARLEYUSMAR, V ;
CROSS, CE ;
HALLIWELL, B .
BIOCHEMICAL JOURNAL, 1994, 303 :295-301
[97]  
VIRAG L, PHARM REV, V54, P375
[98]   Nitric oxide synthesis is increased in patients with systemic lupus erythematosus [J].
Wanchu, A ;
Khullar, M ;
Deodhar, SD ;
Bambery, P ;
Sud, A .
RHEUMATOLOGY INTERNATIONAL, 1998, 18 (02) :41-43
[99]   Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains [J].
Whiteman, M ;
Armstrong, JS ;
Cheung, NS ;
Siau, JL ;
Rose, P ;
Schantz, JT ;
Jones, DP ;
Halliwell, B .
FASEB JOURNAL, 2004, 18 (10) :1395-+
[100]   Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer [J].
Wiseman, H ;
Halliwell, B .
BIOCHEMICAL JOURNAL, 1996, 313 :17-29